Caxton Associates (New York)’s 10x Genomics TXG Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-7,551	Closed	-$574K	–	717
2022 Q1	$574K	Buy	+7,551	New	+$574K	0.05%	193
2021 Q3	–	Sell	-1,893	Closed	-$371K	–	579
2021 Q2	$371K	Buy	+1,893	New	+$371K	0.04%	227